In 2023, the actual mortality rate for trachea, bronchus, or lung malignant neoplasms in Japan was recorded at 16.5 deaths per 100,000 women, standardized rates. Forecast data predicts a gradual decline, with rates expected to dip from 16.4 in 2024 to 16.0 by 2028. This represents a modest year-on-year decline of around 0.6% from 2024 onwards.

Key trends over the next five years include:

A consistent downward trend in mortality rates, with a projected CAGR of approximately -0.61%.
Factors such as advancements in medical treatments and public health campaigns could further impact these trends.

Future trends to watch for include:

Impact of new healthcare policies aimed at reducing smoking rates and improving air quality.
Technological advancements in early detection and treatment of lung-related cancers.
Potential shifts in demographics and population health behaviors influencing cancer incidence and outcomes.